Clinical Response and Safety of Alternating Daily Dosage of Crizotinib due to Side Effects in Advanced NSCLC patient harboring ROS1-rearrangement: A Case Report. (2023). Jurnal Respirologi Indonesia, 43(2), 111-115. https://doi.org/10.36497/jri.v43i2.201